A phase I trial of erlotinib and concurrent chemoradiotherapy for stage III and IV (M0) squamous cell carcinoma of the head and neck.

Gilbert J, Rudek MA, Higgins MJ, Zhao M, Bienvenu S, Tsottles N, Chaudhry MA, Wahl R, Forastiere A, Gillison M
Clin Cancer Res. 2012 18 (6): 1735-42

PMID: 22271880 · PMCID: PMC3306472 · DOI:10.1158/1078-0432.CCR-11-2544

MeSH Terms (14)

Adult Aged Antineoplastic Combined Chemotherapy Protocols Carcinoma, Squamous Cell Chemoradiotherapy Cisplatin Dose Fractionation, Radiation Erlotinib Hydrochloride Head and Neck Neoplasms Humans Male Maximum Tolerated Dose Middle Aged Quinazolines

Connections (1)

This publication is referenced by other Labnodes entities:

Links